The upregulation of NAP1L1 increased its binding with c-Myc and thereby activated c-Myc, inducing the expression of CCND1/CDK4 and thereby promoting glioma cell temozolomide resistance and proliferation. Here, CCND1 is linked to central nervous system cancer.